IN TODAY'S NEWSLETTER:
- FDA approves first AI tool to predict breast cancer risk
- Kesha changes cover art for 'Delusional' single after fan backlash over AI image
- OpenAI to appeal copyright ruling in NY Times case as Altman calls for 'AI privilege'
SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk.
'WE WILL FIGHT': OpenAI CEO Sam Altman said Thursday that the company plans to appeal a court decision in a copyright case brought by The New York Times.
NOVA IN ACTION: Flock Safety has released another piece of revolutionary tec...